TY - JOUR AU - Fowler, A. AU - Koenen, R. AU - Hilbert, J. AU - Blatchford, J. AU - Kappeler, D. AU - Benediktus, E. AU - Wood, C. AU - Gupta, A. PY - 2017 DA - 2017// TI - Safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel CRTH2 antagonist BI 1021958 at single oral doses in healthy men and multiple oral doses in men and women with well-controlled asthma JO - J Clin Pharmacol VL - 57 UR - https://doi.org/10.1002/jcph.947 DO - 10.1002/jcph.947 ID - Fowler2017 ER - TY - JOUR AU - To, T. AU - Stanojevic, S. AU - Moores, G. AU - Gershon, A. S. AU - Bateman, E. D. AU - Cruz, A. A. AU - Boulet, L. P. PY - 2012 DA - 2012// TI - Global asthma prevalence in adults: findings from the cross-sectional world health survey JO - BMC Public Health VL - 12 UR - https://doi.org/10.1186/1471-2458-12-204 DO - 10.1186/1471-2458-12-204 ID - To2012 ER - TY - JOUR AU - Ichinose, M. AU - Sugiura, H. AU - Nagase, H. AU - Yamaguchi, M. AU - Inoue, H. AU - Sagara, H. AU - Tamaoki, J. AU - Tohda, Y. AU - Munakata, M. AU - Yamauchi, K. PY - 2017 DA - 2017// TI - Japanese guidelines for adult asthma 2017 JO - Allergol Int VL - 66 UR - https://doi.org/10.1016/j.alit.2016.12.005 DO - 10.1016/j.alit.2016.12.005 ID - Ichinose2017 ER - TY - STD TI - Global Initiative for Asthma. In: Global Initiative for Asthma 2019. https://ginasthma.org. UR - https://ginasthma.org ID - ref4 ER - TY - JOUR AU - Schlender, A. AU - Alperin, P. E. AU - Grossman, H. L. AU - Sutherland, E. R. PY - 2012 DA - 2012// TI - Modeling the impact of increased adherence to asthma therapy JO - PLoS ONE VL - 7 UR - https://doi.org/10.1371/journal.pone.0051139 DO - 10.1371/journal.pone.0051139 ID - Schlender2012 ER - TY - JOUR AU - Chuchalin, A. G. AU - Tsoi, A. N. AU - Richter, K. AU - Krug, N. AU - Dahl, R. AU - Luursema, P. B. AU - Cameron, R. AU - Bao, W. AU - Higgins, M. AU - Woessner, R. PY - 2007 DA - 2007// TI - Safety and tolerability of indacaterol in asthma: a randomized, placebo-controlled 28-day study JO - Respir Med VL - 101 UR - https://doi.org/10.1016/j.rmed.2007.06.002 DO - 10.1016/j.rmed.2007.06.002 ID - Chuchalin2007 ER - TY - JOUR AU - Stoloff, S. W. AU - Stempel, D. A. AU - Meyer, J. AU - Stanford, R. H. AU - Carranza Rosenzweig, J. R. PY - 2004 DA - 2004// TI - Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies JO - J Allergy Clin Immunol VL - 113 UR - https://doi.org/10.1016/j.jaci.2003.10.011 DO - 10.1016/j.jaci.2003.10.011 ID - Stoloff2004 ER - TY - JOUR AU - Cazzola, M. AU - Bardaro, F. AU - Stirpe, E. PY - 2013 DA - 2013// TI - The role of indacaterol for chronic obstructive pulmonary disease (COPD) JO - J Thorac Dis VL - 5 ID - Cazzola2013 ER - TY - JOUR AU - LaForce, C. AU - Alexander, M. AU - Deckelmann, R. AU - Fabbri, L. M. AU - Aisanov, Z. AU - Cameron, R. AU - Owen, R. AU - Higgins, M. PY - 2008 DA - 2008// TI - Indacaterol provides sustained 24 h bronchodilation on once-daily dosing in asthma: a 7-day dose-ranging study JO - Allergy VL - 63 UR - https://doi.org/10.1111/j.1398-9995.2007.01555.x DO - 10.1111/j.1398-9995.2007.01555.x ID - LaForce2008 ER - TY - JOUR AU - Beier, J. AU - Hosoe, M. AU - Tanase, A. M. AU - Takahashi, Y. AU - Kataoka, N. AU - Hederer, B. PY - 2014 DA - 2014// TI - Efficacy and safety of indacaterol acetate on ICS background therapy in asthma JO - Eur Respir J VL - 44 ID - Beier2014 ER - TY - JOUR AU - Marin, J. M. AU - Clemens, A. AU - Casamor, R. AU - Castellani, W. AU - Schaper, L. AU - Saralaya, D. AU - Gunstone, A. AU - Kostikas, K. AU - Aalamian-Mattheis, M. AU - Beeh, K. PY - 2015 DA - 2015// TI - Effect of glycopyrronium vs tiotropium on pulmonary function and morning symptoms in patients with moderate-to-severe COPD: the SPRING study JO - Eur Respir J VL - 46 ID - Marin2015 ER - TY - JOUR AU - Paggiaro, P. AU - Georges, G. AU - Scuri, M. AU - Valente, I. AU - Guasconi, A. AU - Corre, S. AU - Papi, A. PY - 2018 DA - 2018// TI - Efficacy and safety of extrafine glycopyrronium bromide (GB) in uncontrolled asthmatic patients JO - Eur Respir J VL - 52 ID - Paggiaro2018 ER - TY - JOUR AU - Calverley, P. M. A. AU - Rennard, S. AU - Nelson, H. S. AU - Karpel, J. P. AU - Abbate, E. H. AU - Stryszak, P. AU - Staudinger, H. PY - 2008 DA - 2008// TI - One-year treatment with mometasone furoate in chronic obstructive pulmonary disease JO - Respir Res VL - 9 UR - https://doi.org/10.1186/1465-9921-9-73 DO - 10.1186/1465-9921-9-73 ID - Calverley2008 ER - TY - JOUR AU - Amar, N. J. AU - Shekar, T. AU - Varnell, T. AU - Mehta, A. AU - Philip, G. PY - 2016 DA - 2016// TI - Mometasone furoate (MF) improves lung function in pediatric asthma: a dose-ranging study of mf metered-dose inhaler (MDI) JO - J Allergy Clin Immunol VL - 137 UR - https://doi.org/10.1016/j.jaci.2015.12.1286 DO - 10.1016/j.jaci.2015.12.1286 ID - Amar2016 ER - TY - JOUR AU - Yasuda, S. AU - Zhang, L. AU - Huang, S. -. M. PY - 2008 DA - 2008// TI - The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies JO - Clin Pharmacol Ther VL - 84 UR - https://doi.org/10.1038/clpt.2008.141 DO - 10.1038/clpt.2008.141 ID - Yasuda2008 ER - TY - JOUR AU - Johnson, J. A. PY - 1997 DA - 1997// TI - Influence of race or ethnicity on pharmacokinetics of drugs JO - J Pharm Sci VL - 86 UR - https://doi.org/10.1021/js9702168 DO - 10.1021/js9702168 ID - Johnson1997 ER - TY - JOUR AU - Wood, A. J. PY - 1998 DA - 1998// TI - Ethnic differences in drug disposition and response JO - Ther Drug Monit VL - 20 UR - https://doi.org/10.1097/00007691-199810000-00013 DO - 10.1097/00007691-199810000-00013 ID - Wood1998 ER - TY - JOUR AU - Hosoe, M. AU - Woessner, R. AU - Matsushima, S. AU - Lawrence, D. AU - Kramer, B. PY - 2011 DA - 2011// TI - Efficacy, safety and pharmacokinetics of indacaterol in Caucasian and Japanese patients with chronic obstructive pulmonary disease: a comparison of data from two randomized, placebo-controlled studies JO - Clin Drug Investig VL - 31 UR - https://doi.org/10.2165/11586520-000000000-00000 DO - 10.2165/11586520-000000000-00000 ID - Hosoe2011 ER - TY - JOUR AU - Matsushima, S. AU - Matthews, I. AU - Woessner, R. AU - Pinault, G. AU - Hara, H. AU - Wilkins, J. AU - Sekiguchi, K. PY - 2012 DA - 2012// TI - Systemic pharmacokinetics of indacaterol, an inhaled once-daily long-acting beta2-agonist, in different ethnic populations JO - Int J Clin Pharmacol Ther VL - 50 UR - https://doi.org/10.5414/CP201719 DO - 10.5414/CP201719 ID - Matsushima2012 ER - TY - STD TI - Asmanex® Twisthaler® 100 μg 60 doses/Asmanex® Twisthaler® 200 μg 60 doses—Japanese Package Insert for Asmanex® Twisthaler®, version 2, March 2020 (in Japanese). ID - ref20 ER - TY - JOUR AU - Dolovich, M. A. PY - 2000 DA - 2000// TI - Influence of inspiratory flow rate, particle size and airway caliber on aerosolized drug delivery to the lung JO - Resp Care VL - 45 ID - Dolovich2000 ER - TY - JOUR AU - Buhl, R. AU - Tanase, A. M. AU - Hosoe, M. AU - Cao, W. AU - Demin, I. AU - Bartels, C. AU - Jauernig, J. AU - Ziegler, D. AU - Patalano, F. AU - Hederer, B. AU - Kanniess, F. AU - Tillmann, H. C. PY - 2020 DA - 2020// TI - A randomized, double-blind study to compare the efficacy and safety of two doses of mometasone furoate delivered via Breezhaler® or Twisthaler® in patients with asthma JO - Pulm Pharmacol Ther VL - 62 UR - https://doi.org/10.1016/j.pupt.2020.101919 DO - 10.1016/j.pupt.2020.101919 ID - Buhl2020 ER - TY - JOUR AU - Shimada, S. AU - Vaidya, S. AU - Khindri, S. AU - Tashiro, N. AU - Cheng, Y. AU - Hara, H. AU - Majumdar, T. AU - Woessner, R. AU - Furihata, K. AU - Kobayashi, K. PY - 2015 DA - 2015// TI - Pharmacokinetics of QMF149 in Japanese versus Caucasian subjects: an open-label, randomized phase I study JO - Int J Clin Pharmacol Ther VL - 53 UR - https://doi.org/10.5414/CP202239 DO - 10.5414/CP202239 ID - Shimada2015 ER - TY - JOUR AU - Myrand, S. AU - Sekiguchi, K. AU - Man, M. AU - Lin, X. AU - Tzeng, R. -. Y. AU - Teng, C. -. H. AU - Hee, B. AU - Garrett, M. AU - Kikkawa, H. AU - Lin, C. -. Y. PY - 2008 DA - 2008// TI - Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation japanese populations: comparison with korean, chinese, and caucasian populations JO - Clin Pharmacol Ther VL - 84 UR - https://doi.org/10.1038/sj.clpt.6100482 DO - 10.1038/sj.clpt.6100482 ID - Myrand2008 ER - TY - STD TI - Onbrez Breezhaler Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/601/smpc. UR - https://www.medicines.org.uk/emc/product/601/smpc ID - ref25 ER - TY - STD TI - Seebri Breezhaler Summary of Product Characteristics. https://www.ema.europa.eu/en/documents/product-information/seebri-breezhaler-epar-product-information_en.pdf. UR - https://www.ema.europa.eu/en/documents/product-information/seebri-breezhaler-epar-product-information_en.pdf ID - ref26 ER - TY - JOUR AU - Affrime, M. B. AU - Kosoglou, T. AU - Thonoor, C. M. AU - Flannery, B. E. AU - Herron, J. M. PY - 2000 DA - 2000// TI - Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses JO - Chest VL - 118 UR - https://doi.org/10.1378/chest.118.6.1538 DO - 10.1378/chest.118.6.1538 ID - Affrime2000 ER - TY - JOUR AU - Kerstjens, H. A. M. AU - Maspero, J. AU - Chapman, K. R. AU - Zyl-Smit, R. N. AU - Hosoe, M. AU - Tanase, A. M. PY - 2020 DA - 2020// TI - Once-daily, single-inhaler mometasone–indacaterol– glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study JO - Lancet Respir Med UR - https://doi.org/10.1016/S2213-2600(20)30190-9 DO - 10.1016/S2213-2600(20)30190-9 ID - Kerstjens2020 ER - TY - JOUR AU - Sagara, H. AU - D’Andrea, P. AU - Tanase, A. M. AU - Pethe, A. AU - Tananka, Y. AU - Matsuo, K. AU - Hosoe, M. PY - 2020 DA - 2020// TI - Once-daily indacaterol acetate, glycopyrronium bromide, and mometasone furoate as a fixed-dose combination in japanese patients with inadequately controlled asthma: a multicenter, 52-week safety study JO - Am J Respir Crit Care Med VL - 201 ID - Sagara2020 ER - TY - JOUR AU - Kato, M. AU - Makita, H. AU - Uemura, K. AU - Fukuchi, Y. AU - Hosoe, M. AU - Emery, C. AU - Higgins, M. AU - Kramer, B. PY - 2010 DA - 2010// TI - Bronchodilator efficacy of single doses of indacaterol in Japanese patients with COPD: a randomised, double-blind, placebo-controlled trial JO - Allergol Int VL - 59 UR - https://doi.org/10.2332/allergolint.10-OA-0173 DO - 10.2332/allergolint.10-OA-0173 ID - Kato2010 ER - TY - JOUR AU - Fukushima, Y. AU - Nakatani, Y. AU - Ide, Y. AU - Sekino, H. AU - Rose, E. S. AU - Siddiqui, S. AU - Maes, A. AU - Reisner, C. PY - 2018 DA - 2018// TI - Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD JO - Int J Chron Obstruct Pulmon Dis VL - 13 UR - https://doi.org/10.2147/COPD.S159246 DO - 10.2147/COPD.S159246 ID - Fukushima2018 ER - TY - JOUR AU - Hashimoto, S. AU - Ikeuchi, H. AU - Murata, S. AU - Kitawaki, T. AU - Ikeda, K. AU - Banerji, D. PY - 2016 DA - 2016// TI - Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study JO - Int J Chron Obstruct Pulmon Dis VL - 11 UR - https://doi.org/10.2147/COPD.S111408 DO - 10.2147/COPD.S111408 ID - Hashimoto2016 ER - TY - JOUR AU - Wedzicha, J. A. AU - Zhong, N. AU - Ichinose, M. AU - Humphries, M. AU - Fogel, R. AU - Thach, C. AU - Patalano, F. AU - Banerji, D. PY - 2017 DA - 2017// TI - Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study JO - Int J Chron Obstruct Pulmon Dis VL - 12 UR - https://doi.org/10.2147/COPD.S125058 DO - 10.2147/COPD.S125058 ID - Wedzicha2017 ER - TY - JOUR AU - Sugihara, N. AU - Kanada, S. AU - Haida, M. AU - Ichinose, M. AU - Adachi, M. AU - Hosoe, M. AU - Emery, C. AU - Higgins, M. AU - Kramer, B. PY - 2010 DA - 2010// TI - 24-h bronchodilator efficacy of single doses of indacaterol in Japanese patients with asthma: a comparison with placebo and salmeterol JO - Respir Med VL - 104 UR - https://doi.org/10.1016/j.rmed.2010.06.011 DO - 10.1016/j.rmed.2010.06.011 ID - Sugihara2010 ER - TY - JOUR AU - Tohda, Y. AU - Miyamoto, T. PY - 2010 DA - 2010// TI - Efficacy, safety, and tolerability of mometasone furoate in adult Japanese patients with mild asthma: open-label clinical trial findings JO - Curr Med Res Opin VL - 26 UR - https://doi.org/10.1185/03007990903422380 DO - 10.1185/03007990903422380 ID - Tohda2010 ER - TY - JOUR AU - Molimard, M. AU - D'Andrea, P. PY - 2013 DA - 2013// TI - Once-daily glycopyrronium via the Breezhaler(R) device for the treatment of COPD: pharmacological and clinical profile JO - Expert Rev Clin Pharmacol VL - 6 UR - https://doi.org/10.1586/17512433.2013.828419 DO - 10.1586/17512433.2013.828419 ID - Molimard2013 ER - TY - JOUR AU - Vaidya, S. S. AU - Khindri, S. AU - Calder, N. AU - Machineni, S. AU - Hara, H. AU - Majumdar, T. AU - Febbraro, S. AU - Fuhr, R. AU - Woessner, R. PY - 2016 DA - 2016// TI - Pharmacokinetics of indacaterol and mometasone furoate delivered alone or in a free or fixed dose combination in healthy subjects JO - Pulm Pharmacol Ther VL - 37 UR - https://doi.org/10.1016/j.pupt.2016.01.004 DO - 10.1016/j.pupt.2016.01.004 ID - Vaidya2016 ER - TY - JOUR AU - Sechaud, R. AU - Renard, D. AU - Zhang-Auberson, L. AU - Motte, S. AU - Drollmann, A. AU - Kaiser, G. PY - 2012 DA - 2012// TI - Pharmacokinetics of multiple inhaled NVA237 doses in patients with chronic obstructive pulmonary disease (COPD) JO - Int J Clin Pharmacol Ther VL - 50 UR - https://doi.org/10.5414/CP201612 DO - 10.5414/CP201612 ID - Sechaud2012 ER -